Early trial tests new drug for autoimmune hair loss
Disease control
Completed
This early-stage study tested the safety and potential effectiveness of an experimental drug called IMG-007 for adults with significant hair loss from alopecia areata. A small group of 29 participants received three intravenous infusions of the drug over four weeks. Researchers m…
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC